These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38471643)

  • 21. Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
    McIntosh CL; Maron BJ; Cannon RO; Klues HG
    Circulation; 1992 Nov; 86(5 Suppl):II60-7. PubMed ID: 1424035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and outcomes of alcohol septal ablation in the era of transcatheter valve interventions.
    Engel Gonzalez P; Gregerson S; Mahmood S; Brooks C; Villablanca PA; Frisoli TM; Lee J; Wyman JF; Wang DD; O'Neill WW; O'Neill BP
    Catheter Cardiovasc Interv; 2024 May; 103(6):1023-1034. PubMed ID: 38639143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valve-in-Valve for Failing Mitral Bioprosthesis With Tip-to-Base LAMPOON to Prevent Left Ventricular Outflow Tract Obstruction.
    Ben-Dor I; Weissman G; Case BC; Satler LF; Waksman R; Rogers T
    Innovations (Phila); 2021; 16(5):409-413. PubMed ID: 34636690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long or redundant leaflet complicating transcatheter mitral valve replacement: Case vignettes that advocate for removal or reduction of the anterior mitral leaflet.
    Greenbaum AB; Condado JF; Eng M; Lerakis S; Wang DD; Kim DW; Lederman RJ; Paone G; Neill WWO; Thourani VH; Babaliaros VC
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):627-632. PubMed ID: 28471059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitral stenosis and hypertrophic obstructive cardiomyopathy: An unusual combination.
    Hong J; Schaff HV; Ommen SR; Abel MD; Dearani JA; Nishimura RA
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):1044-8. PubMed ID: 26724969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Balloon assisted translocation of the mitral anterior leaflet to prevent left ventricular outflow obstruction (BATMAN): A novel technique for patients undergoing transcatheter mitral valve replacement.
    Helmy T; Hui DS; Smart S; Lim MJ; Lee R
    Catheter Cardiovasc Interv; 2020 Mar; 95(4):840-848. PubMed ID: 31515964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simulation of left ventricular outflow tract (LVOT) obstruction in transcatheter mitral valve-in-ring replacement.
    Pasta S; Cannata S; Gentile G; Agnese V; Pilato M; Gandolfo C
    Med Eng Phys; 2020 Aug; 82():40-48. PubMed ID: 32709264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting LVOT Obstruction in Transcatheter Mitral Valve Implantation: Concept of the Neo-LVOT.
    Blanke P; Naoum C; Dvir D; Bapat V; Ong K; Muller D; Cheung A; Ye J; Min JK; Piazza N; Theriault-Lauzier P; Webb J; Leipsic J
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):482-485. PubMed ID: 26971004
    [No Abstract]   [Full Text] [Related]  

  • 29. Novel Multiphase Assessment for Predicting Left Ventricular Outflow Tract Obstruction Before Transcatheter Mitral Valve Replacement.
    Meduri CU; Reardon MJ; Lim DS; Howard E; Dunnington G; Lee DP; Liang D; Gooley R; O'Hair D; Ng MK; Walton A; Spargias K; Blackman D; Coisne A; Hildick-Smith D; De Gouy M; Chenoweth S; Kar S; McCarthy PM; Piazza N; Qasam A; Martin RP; Leon MB; Mack MJ; Adams DH; Bapat V
    JACC Cardiovasc Interv; 2019 Dec; 12(23):2402-2412. PubMed ID: 31629753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter Myotomy to Treat Hypertrophic Cardiomyopathy and Enable Transcatheter Mitral Valve Replacement: First-in-Human Report of Septal Scoring Along the Midline Endocardium.
    Greenbaum AB; Khan JM; Bruce CG; Hanzel GS; Gleason PT; Kohli K; Inci EK; Guyton RA; Paone G; Rogers T; Lederman RJ; Babaliaros VC
    Circ Cardiovasc Interv; 2022 Jun; 15(6):e012106. PubMed ID: 35603621
    [No Abstract]   [Full Text] [Related]  

  • 31. Numerical simulation of transcatheter mitral valve replacement: The dynamic implication of LVOT obstruction in the valve-in-ring case.
    Pasta S; Catalano C; Cannata S; Guccione JM; Gandolfo C
    J Biomech; 2022 Nov; 144():111337. PubMed ID: 36209656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of three-dimensional computational modeling in prediction of the dynamic neo left ventricular outflow tract with transcatheter mitral valve replacement.
    Ooms JF; Ceusters J; Hirsch A; Budde RPJ; Van Mieghem NM
    Int J Cardiol; 2021 Aug; 336():93-96. PubMed ID: 33965466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative Provocative Testing in Patients with Obstructive Hypertrophic Cardiomyopathy Undergoing Septal Myectomy.
    Bedair Elsayes A; Basura A; Zahedi F; Moreno-Duarte I; Rowin EJ; Maron M; Rastegar H; Cobey FC
    J Am Soc Echocardiogr; 2020 Feb; 33(2):182-190. PubMed ID: 31740372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter mitral valve replacement (TMVR): annular or apical fixation?
    Lutter G; Dai H; Hansen JH; Frank D; Haneya A; Simionescu D; Cremer J; Puehler T
    EuroIntervention; 2020 Aug; 16(6):e510-e517. PubMed ID: 31793883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
    Patel P; Dhillon A; Popovic ZB; Smedira NG; Rizzo J; Thamilarasan M; Agler D; Lytle BW; Lever HM; Desai MY
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003132. PubMed ID: 26082555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcohol septal ablation in patients with concomitant hypertrophic cardiomyopathy and aortic valvular stenosis.
    El-Sabawi B; Nishimura RA; Guerrero ME; Rihal CS; Eleid MF
    Catheter Cardiovasc Interv; 2020 Mar; 95(4):830-837. PubMed ID: 31410979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The surgical management of hypertrophic obstructive cardiomyopathy with the concomitant mitral valve abnormalities.
    Cui B; Wang S; Xu J; Wang W; Song Y; Sun H; Zheng Z; Lv F; Xiong H
    Interact Cardiovasc Thorac Surg; 2015 Dec; 21(6):722-6. PubMed ID: 26374266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transaortic Chordal Cutting: Mitral Valve Repair for Obstructive Hypertrophic Cardiomyopathy With Mild Septal Hypertrophy.
    Ferrazzi P; Spirito P; Iacovoni A; Calabrese A; Migliorati K; Simon C; Pentiricci S; Poggio D; Grillo M; Amigoni P; Iascone M; Mortara A; Maron BJ; Senni M; Bruzzi P
    J Am Coll Cardiol; 2015 Oct; 66(15):1687-96. PubMed ID: 26449139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neo-LVOT and Transcatheter Mitral Valve Replacement: Expert Recommendations.
    Reid A; Ben Zekry S; Turaga M; Tarazi S; Bax JJ; Wang DD; Piazza N; Bapat VN; Ihdayhid AR; Cavalcante JL; Blanke P; Leipsic J
    JACC Cardiovasc Imaging; 2021 Apr; 14(4):854-866. PubMed ID: 33248959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Predicted and Confirmed Neo-Left Ventricular Outflow Tract After Transcatheter Mitral Valve Replacement.
    Puehler T; Blanke P; Seoudy H; Sathananthan J; Sellers SL; Meier D; Both M; Saad M; Frank D; Søndergaard L; Lutter G
    JACC Cardiovasc Interv; 2022 Oct; 15(20):e219-e221. PubMed ID: 36265952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.